Warren Anne G, Janz Brian A, Slavin Sumner A, Borud Loren J
Harvard Medical School, Boston, MA 02215, USA.
Ann Plast Surg. 2007 May;58(5):541-3. doi: 10.1097/01.sap.0000244977.84130.cf.
Lymphedema, a chronic disfiguring condition resulting from lymphatic dysfunction or disruption, can be difficult to accurately diagnose and manage. Of particular challenge is identifying the presence of clinically significant limb swelling through simple and noninvasive methods. Many historical and currently used techniques for documenting differences in limb volume, including volume displacement and circumferential measurements, have proven difficult and unreliable. Bioimpedance spectroscopy analysis, a technology that uses resistance to electrical current in comparing the composition of fluid compartments within the body, has been considered as a cost-effective and reproducible alternative for evaluating patients with suspected lymphedema.
All patients were recruited through the Beth Israel Deaconess Medical Center Lymphedema Clinic. A total of 15 patients (mean age: 55.2 years) with upper-extremity or lower-extremity lymphedema as documented by lymphoscintigraphy underwent bioimpedance spectroscopy analysis using an Impedimed SFB7 device. Seven healthy medical students and surgical residents (mean age: 26.9 years) were selected to serve as normal controls. All study participants underwent analysis of both limbs, which allowed participants to act as their own controls. The multifrequency bioimpedance device documented impedance values for each limb, with lower values correlating with higher levels of accumulated protein-rich edematous fluid.
The average ratio of impedance to current flow of the affected limb to the unaffected limb in lymphedema patients was 0.9 (range: 0.67 to 1.01). In the control group, the average impedance ratio of the participant's dominant limb to their nondominant limb was 0.99 (range: 0.95 to 1.02) (P = 0.01).
Bioimpedance spectroscopy can be used as a reliable and accurate tool for documenting the presence of lymphedema in patients with either upper- or lower-extremity swelling. Measurement with the device is quick and simple and results are reproducible among patients. Given significant limitations with other methods of evaluating lymphedema, the use of bioimpedance analysis may aid in the diagnosis of lymphedema and allow for tracking patients over time as they proceed with treatment of their disease.
淋巴水肿是一种因淋巴功能障碍或破坏导致的慢性毁容性疾病,可能难以准确诊断和管理。特别具有挑战性的是通过简单且非侵入性的方法来确定临床上显著的肢体肿胀是否存在。许多用于记录肢体体积差异的传统及当前使用的技术,包括体积置换法和周径测量法,已被证明既困难又不可靠。生物电阻抗光谱分析是一种利用电流电阻来比较体内液体腔室组成的技术,已被视为评估疑似淋巴水肿患者的一种经济有效且可重复的替代方法。
所有患者均通过贝斯以色列女执事医疗中心淋巴水肿诊所招募。共有15例经淋巴闪烁造影证实患有上肢或下肢淋巴水肿的患者(平均年龄:55.2岁)使用Impedimed SFB7设备进行了生物电阻抗光谱分析。选取7名健康医学生和外科住院医师(平均年龄:26.9岁)作为正常对照。所有研究参与者均对双侧肢体进行了分析,这使得参与者可作为自身对照。多频生物电阻抗设备记录了每个肢体的阻抗值,较低的值与富含蛋白质的水肿液积聚水平较高相关。
淋巴水肿患者患侧肢体与未患侧肢体的阻抗与电流流动平均比值为0.9(范围:0.67至1.01)。在对照组中,参与者优势肢体与非优势肢体的平均阻抗比值为0.99(范围:0.95至1.02)(P = 0.01)。
生物电阻抗光谱分析可作为记录上肢或下肢肿胀患者淋巴水肿存在情况的可靠且准确的工具。使用该设备进行测量快速且简单,并且在患者中结果具有可重复性。鉴于评估淋巴水肿的其他方法存在显著局限性,生物电阻抗分析的应用可能有助于淋巴水肿的诊断,并能随着患者疾病治疗进程对其进行长期跟踪。